Biomarkers in lupus nephritis

Systemic lupus erythematosus is a polysystemic autoimmune disease. One of the most common and serious complication is lupus nephritis. Notification of these complications before organic disorder, prediction of flares, starting aggressive therapy as early as possible, and the follow-up of successful...

Full description

Saved in:
Bibliographic Details
Published inOrvosi hetilap Vol. 151; no. 29; p. 1171
Main Authors Brúgós, Boglárka, Zeher, Margit
Format Journal Article
LanguageHungarian
Published Hungary 18.07.2010
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Systemic lupus erythematosus is a polysystemic autoimmune disease. One of the most common and serious complication is lupus nephritis. Notification of these complications before organic disorder, prediction of flares, starting aggressive therapy as early as possible, and the follow-up of successful treatment would be desirable. There is an intensive need for identifying the best biomarker for monitoring flare activity. The goal of this review is to present not only the most frequently ordered serologic tests, but the latest, partly experimental biomarkers reflecting flares, which are not used in clinical practice. Biomarkers used specifically in lupus nephritis are also described.
ISSN:0030-6002